Pillstats
OTC · Ointment · Topical

Dibucaine

Brands: Cvs Topical Analgesic Hemorrhoidal · Dibucaine

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)3339
US makers3 labelers
Packages4
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.047$0.094$0.141$0.188Dec 2025Apr 2026Jul 2026
$0.163
Latest avg · Jul 22, 2026
+3%
Since Dec 17, 2025
3
Active US suppliers
75%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1623244866492025 Q12025 Q22025 Q32025 Q42026 Q1
450
Rx · 2026 Q1
9.1K
Units dispensed
-10%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Akron Pharma Inc.unknown2SUPPLYING
Rugby Laboratoriesunknown1SUPPLYING
CVS Pharmacyunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Feb 17, 2023
    RECALLRecall (Class III): DIBUCAINE 1% HEMORRHOIDAL OINTMENT, 1 oz. (28 gm), Manufactured for: Akron Pharma Inc. Fairfield NJ 07004, NDC 71399-28…

    Labeling: Incorrect or Missing Lot and/or Exp Date — Recalling firm: Akron Pharma, Inc. — Nationwide within the United States

  • Mar 15, 2021
    RECALLRecall (Class II): DIBUCAINE TOPICAL ANESTHETIC 1% HEMORRHOIDAL OINTMENT 28GM ; NDC/UPC 0536-1211-95; OTC; OINTMENT

    CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC